Guidance for the notification of serious breaches of GCP or the trial protocol
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
F. Potential actions by the MHRA
Appendix I: Notification Examples
Appendix II: Notification Form
Clinical Research News
今後の臨床試験
-
NCT02960555採用条件：くすぶり型形質細胞骨髄腫
-
NCT04591483採用条件：スターガルト病の黄斑ジス
-
NCT04270747採用条件：新生血管（ウェット）加齢性黄斑変性症（AMD）
-
NCT04289220採用条件：B Cell Lymphoma, B細胞性芽球性白血病
-
NCT03829462採用条件：転移性結腸がん（mCRC）
-
NCT04136184採用条件：遺伝性トランスチレチンパラメータ性アホ多発神経障害
-
NCT04181723採用条件：nära
-
NCT00055029採用条件：網膜分離症
-
NCT00050752採用条件：Renal Tumor Histology, 皮膚平滑筋腫, 腎臓がん
-
NCT00076830採用条件：結合組織障害, 骨形成不全症, 骨の病気、代謝, 流蝋骨症
Recent CRA jobs
-
Patient Recruitment Specialist - FSP
-
Sr. Project Quality & Risk Lead
-
Clinical Operations Manager, FSP
-
Senior HRBP [Limited Period - 13 months]
-
Medical Writer 1
-
Associate Medical Writer
-
Sr. CRA FSP Clinical
-
Senior Clinical Research Associate FSP Clinical
-
Associate Director, Clinical Feasibility
-
Lab Validation Specialist